Circulating fibrinogen is a prognostic and predictive biomarker in malignant pleural mesothelioma

被引：0
|
作者：
B Ghanim
M A Hoda
T Klikovits
M-P Winter
A Alimohammadi
M Grusch
B Dome
M Arns
P Schenk
M Jakopovic
M Samarzija
L Brcic
M Filipits
V Laszlo
W Klepetko
W Berger
B Hegedus
机构：
[1] Medical University of Vienna,Division of Thoracic Surgery, Department of Surgery
[2] Institute of Cancer Research,Department of Internal Medicine I
[3] Medical University of Vienna,Department of Thoracic Surgery
[4] National Koranyi Institute of Pulmonology,Department of Pulmonology
[5] National Institute of Oncology,Department for Respiratory Diseases Jordanovac
[6] LKH Hochegg,Department of Biological Physics
[7] University of Zagreb,undefined
[8] School of Medicine,undefined
[9] University Hospital Center,undefined
[10] University of Zagreb,undefined
[11] School of Medicine,undefined
[12] Institute of Pathology,undefined
[13] Eötvös University,undefined
[14] MTA-SE Molecular Oncology Research Group,undefined
[15] Hungarian Academy of Sciences,undefined
来源：
British Journal of Cancer | 2014年 / 110卷
关键词：
malignant pleural mesothelioma; fibrinogen; prognosis; predictive biomarker; multimodality therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：984 / 990
页数：6
相关论文
共 50 条
  • [11] Prognostic factors for malignant pleural mesothelioma
    Brims, Fraser J. H.
    Maskell, Nick A.
    CURRENT PULMONOLOGY REPORTS, 2013, 2 (02) : 100 - 108
  • [12] Prognostic factors in malignant pleural mesothelioma
    Davidson, Ben
    HUMAN PATHOLOGY, 2015, 46 (06) : 789 - 804
  • [13] New insights from KISS activity: a prognostic biomarker in malignant pleural mesothelioma
    Ciaramella, V.
    Della Corte, C. M.
    Papaccio, F.
    Giuseppe, V.
    Esposito, G.
    Fasano, M.
    Martinelli, E.
    Troiani, T.
    Ciardiello, F.
    Morgillo, F.
    ANNALS OF ONCOLOGY, 2016, 27
  • [14] Prognostic characteristics of malignant pleural mesothelioma
    Metintas, Muzaffer
    Ak, Guntulu
    Metintas, Selma
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [15] Prognostic Factors in Malignant Pleural Mesothelioma
    Kirschner, M.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S12 - S12
  • [16] PROGNOSTIC BIOMARKERS IN MALIGNANT PLEURAL MESOTHELIOMA
    Mezzapelle, R.
    Miglio, U.
    Rena, O.
    Mercalli, F.
    Veggiani, C.
    Paganotti, A.
    Buosi, R.
    Rinaldi, M.
    Boldorini, R.
    ANNALS OF ONCOLOGY, 2014, 25
  • [17] Detection of circulating immunosuppressive cytokines in malignant pleural mesothelioma patients for prognostic stratification
    Urso, Loredana
    Silic-Benussi, Micol
    Boscolo, Alice
    Lorenzi, Martina
    Bonanno, Laura
    Lunardi, Francesca
    Guarneri, Valentina
    Calabrese, Fiorella
    Rea, Federico
    Conte, PierFranco
    Pasello, Giulia
    CYTOKINE, 2021, 146
  • [18] CIRCULATING MIR-625-3P: A POTENTIAL BIOMARKER FOR MALIGNANT PLEURAL MESOTHELIOMA
    Kirschner, M. B.
    Cheng, Y. Y.
    Badrian, B.
    Kao, S. C.
    Creaney, J.
    Edelman, J. J. B.
    Harvie, R.
    Armstrong, N. J.
    Vallely, M. P.
    Musk, A. W.
    Robinson, B. W. S.
    McCaughan, B. C.
    Pavlakis, N.
    Klebe, S.
    Mutsaers, S. E.
    van Zandwijk, N.
    Reid, G.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (09) : S174 - S174
  • [19] Prognostic and Predictive Factors Affecting Course of Disease and Survival in Malignant Pleural Mesothelioma
    De Palma, Angela
    Loizzi, Michele
    Prisciandaro, Elena
    Pizzuto, Ondina
    Pezzuto, Federica
    Punzi, Alessandra
    Scattone, Anna
    Marzullo, Andrea
    Serio, Gabriella
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1376 - S1377
  • [20] Circulating Endothelial Cell (CEC) as a Diagnostic and Prognostic Marker in Malignant Pleural Mesothelioma (MPM)
    Yoneda, Kazue
    Tanaka, Fumihiro
    Kondo, Nobuyuki
    Orui, Hayato
    Hashimoto, Masaki
    Takuwa, Teruhisa
    Matsumoto, Seiji
    Okumura, Yoshitomo
    Tsubota, Noriaki
    Sato, Ayuko
    Tsujimura, Tohru
    Kuribayashi, Kozo
    Fukuoka, Kazuya
    Nakano, Takashi
    Hasegawa, Seiki
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (13) : 4229 - 4237
12345